Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F9 | P00740 | 8/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | F10 | P00742 | 5/20 | 0.31 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.31 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.30 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.30 |
| ▸ | PIM1 | P11309 | 1/20 | 0.30 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.30 |
| ▸ | CSF3R | Q99062 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16169701 | 0.96 | CSF3R (0.36) | F9L3MBTL1PIM1PIM2CSF3R | |
| SCHEMBL15805867 | 0.94 | F9 (0.36) | F9F10CHEK1 | |
| SCHEMBL16169703 | 0.90 | PIM1 (0.33) | PIM1PIM2CSF3R | |
| SCHEMBL16169705 | 0.87 | F9 (0.32) | F9F10MTNR1AMTNR1B | |
| SCHEMBL16419736 | 0.83 | L3MBTL1 (0.40) | L3MBTL1F10MTNR1AMTNR1B | |
| SCHEMBL16172090 | 0.81 | F9 (0.33) | F9F10 | |
| SCHEMBL16419740 | 0.80 | L3MBTL1 (0.45) | L3MBTL1F10MTNR1AMTNR1B | |
| SCHEMBL16284389 | 0.78 | F10 (0.43) | F9L3MBTL1F10MTNR1AMTNR1B | |
| SCHEMBL16419774 | 0.77 | ABL1 (0.35) | F9L3MBTL1F10 | |
| SCHEMBL15037015 | 0.77 | PRSS1 (0.42) | L3MBTL1F10MTNR1AMTNR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140308317-A1 | Polymeric Compounds And Methods Of Making And Using The Same | CELLCEUTIX CORPORATION (US) | 2014-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140308317-A1 | Polymeric Compounds And Methods Of Making And Using The Same | ALG1, CD44, MUC1 | F9 1851/4885L3MBTL1 1079/4885F10 1448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.